Search clinical trials for: TAK-931
Total 5087 results
-
TakedaCompleted
-
TakedaCompletedHealthy VolunteersUnited States
-
TakedaRecruitingGeneralized Pustular Psoriasis | Erythrodermic PsoriasisJapan
-
TakedaRecruitingNarcolepsy Type 1 | Narcolepsy Type 2Spain, Germany, United States, Italy, Netherlands, Japan, France, Norway, Australia, Finland, Switzerland, Sweden
-
TakedaTakeda Development Center Americas, Inc.RecruitingUnresectable Locally Advanced or Metastatic CancerUnited States, Australia
-
TakedaActive, not recruiting
-
TakedaCompletedCoronavirus Disease (COVID-19)Japan
-
Calithera Biosciences, IncWithdrawnLymphoma, Malignant | Advanced Solid NeoplasmsUnited States
-
Calithera Biosciences, IncTerminatedLymphoma, Non-Hodgkin | Lymphoma, Follicular, Marginal ZoneKorea, Republic of, Japan
-
Calithera Biosciences, IncTerminatedAcute Myelogenous LeukemiaUnited States, Canada
-
TakedaCompletedHealthy VolunteersUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Nonhematological MalignanciesUnited States
-
TakedaCompletedErosive EsophagitisJapan
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
TakedaTerminatedDiabetic Neuropathies
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid TumorsUnited States
-
TakedaCompletedDiabetes Mellitus, Type 2
-
Millennium Pharmaceuticals, Inc.CompletedSolid TumorsUnited States
-
TakedaRecruitingRenal Impairment | Healthy VolunteersUnited States
-
TakedaCompleted
-
TakedaCompletedBreast Neoplasm | Ovarian Neoplasm | Pancreatic Neoplasm | Lung Neoplasm | Renal NeoplasmUnited States
-
TakedaCompletedHealthy VolunteersUnited States
-
TakedaTerminatedLow TestosteroneUnited States
-
Calithera Biosciences, IncWithdrawnAdvanced Solid Neoplasms | Lymphoma Neoplasms
-
Millennium Pharmaceuticals, Inc.Completed
-
TakedaCompletedAutoimmune DiseaseUnited Kingdom
-
Millennium Pharmaceuticals, Inc.Completed
-
TakedaActive, not recruitingNarcolepsy Type 2Spain, United States, Japan, Italy, France, Germany, Australia, Netherlands, Finland, Norway, Sweden, Switzerland
-
TakedaCompletedHealthy Participants and Patients With NarcolepsyJapan
-
TakedaCompleted
-
TakedaCompletedDiabetic NeuropathiesUnited States, Canada
-
TakedaCompletedAscending Single Dose Study
-
TakedaCompletedNon-erosive Gastroesophageal Reflux DiseaseJapan
-
TakedaTerminated
-
TakedaNot yet recruiting
-
TakedaCompletedNarcolepsy Type 1Spain, Japan, France, Germany, United States, Norway, Netherlands, Finland, Switzerland, Australia, Italy, Sweden
-
TakedaActive, not recruitingPrimary Immune ThrombocytopeniaSpain, United States, Croatia, Italy, China, Germany, Bulgaria, Greece, Slovenia, Japan, Ukraine
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan
-
TakedaTerminatedNarcolepsy Type 1 (NT1) | Narcolepsy Type 2 (NT2)China, United States, Korea, Republic of, France, Italy, Finland, Spain, Czechia, Canada, Japan, Hungary, Netherlands
-
TakedaMichael J. Fox Foundation for Parkinson's ResearchCompletedParkinson Disease | Healthy ParticipantsUnited States
-
TakedaCompletedHealthy Participants | NarcolepsyJapan
-
Millennium Pharmaceuticals, Inc.Completed
-
TakedaCompleted
-
TakedaCompletedDiabetes Mellitus
-
TakedaCompletedDiabetic NeuropathiesUnited States, Canada